12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Response Genetics sales and marketing update

Response Genetics added both FISH- and PCR-based testing for c-ros proto-oncogene 1 receptor tyrosine kinase (ROS1) gene rearrangements to its lung cancer panel. The company said ROS1 testing...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >